PULVOMYCIN-RESISTANT MUTANTS OF ESCHERICHIA-COLI ELONGATION-FACTOR TU

被引:38
作者
ZEEF, LAH
BOSCH, L
ANBORGH, PH
CETIN, R
PARMEGGIANI, A
HILGENFELD, R
机构
[1] ECOLE POLYTECH,BIOCHIM LAB,CNRS,SDI 61840,F-91128 PALAISEAU,FRANCE
[2] HOECHST AG,CENT RES G 865A,PROT CRYSTALLOG,D-65926 FRANKFURT,GERMANY
关键词
AMINOACYL-TRANSFER-RNA; EF-TU; GTP BINDING PROTEIN; KIRROMYCIN; RIBOSOME;
D O I
10.1002/j.1460-2075.1994.tb06840.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This paper reports the generation of Escherichia coli mutants resistant to pulvomycin. Together with targeted mutagenesis of the tufA gene, conditions were found to overcome membrane impermeability, thereby allowing the selection of three mutants harbouring elongation factor (EF)-Tu Arg230 --> Cys, Arg333 --> Cys or Thr334 --> Ala which confer pulvomycin resistance. These mutations are clustered in the three-domain junction interface of the crystal structure of the GTP form of Thermus thermophilus EF-Tu. This result shares similarities with kirromycin resistance; kirromycin-resistant mutations cluster in the domain 1-3 interface. Since both interface regions are involved in the EF-Tu switch mechanism, we propose that pulvomycin and kirromycin both act by specifically disturbing the allosteric changes required for the switch from EF-Tu.GTP to EF-Tu.GDP. The three-domain junction changes dramatically in the switch to EF-Tu.GTP; in EF-Tu.GDP this region forms an open hole. Structural analysis of the mutation positions in EF-Tu.GTP indicated that the two most highly resistant mutants, R230C and R333C, are part of an electrostatic network involving numerous residues. All three mutations appear to destabilize the EF-Tu.GTP conformation. Genetic and protein characterizations show that sensitivity to pulvomycin is dominant over resistance. This appears to contradict the currently accepted model of protein synthesis inhibition by pulvomycin.
引用
收藏
页码:5113 / 5120
页数:8
相关论文
共 50 条
[1]   KIRROMYCIN DRASTICALLY REDUCES THE AFFINITY OF ESCHERICHIA-COLI ELONGATION-FACTOR TU FOR AMINOACYL-TRANSFER RNA [J].
ABRAHAMS, JP ;
VANRAAIJ, MJ ;
OTT, G ;
KRAAL, B ;
BOSCH, L .
BIOCHEMISTRY, 1991, 30 (27) :6705-6710
[2]  
AKITA E, 1964, J ANTIBIOT, V17, P200
[3]  
AKITA E, 1963, J ANTIBIOT, V16, P147
[4]   KIRROMYCIN-INDUCED MODIFICATIONS FACILITATE THE SEPARATION OF EF-TU SPECIES AND REVEAL INTERMOLECULAR INTERACTIONS [J].
ANBORGH, PH ;
SWART, GWM ;
PARMEGGIANI, A .
FEBS LETTERS, 1991, 292 (1-2) :232-236
[5]   SITE-DIRECTED MUTAGENESIS OF ELONGATION-FACTOR TU - THE FUNCTIONAL AND STRUCTURAL ROLE OF RESIDUE CYS81 [J].
ANBORGH, PH ;
PARMEGGIANI, A ;
JONAK, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 208 (02) :251-257
[6]   NEW ANTIBIOTIC THAT ACTS SPECIFICALLY ON THE GTP-BOUND FORM OF ELONGATION FACTOR-TU [J].
ANBORGH, PH ;
PARMEGGIANI, A .
EMBO JOURNAL, 1991, 10 (04) :779-784
[7]  
ANBORGH PH, 1993, THESIS LEIDEN U NETH
[8]   CRYSTAL-STRUCTURE OF ACTIVE ELONGATION-FACTOR TU REVEALS MAJOR DOMAIN REARRANGEMENTS [J].
BERCHTOLD, H ;
RESHETNIKOVA, L ;
REISER, COA ;
SCHIRMER, NK ;
SPRINZL, M ;
HILGENFELD, R .
NATURE, 1993, 365 (6442) :126-132
[9]  
BERGET PB, 1988, ADV BACTERIAL GENETI
[10]  
BOECKE JD, 1982, MOL GEN GENET, V186, P185